▶주메뉴 바로가기
▶본문 바로가기
South Korea’s biotherapeutics firm SillaJen announced on March 20 that it has decided to secure additional funds worth 110 billion won ($97.31 million) through issuing convertible bonds. The compa...
Korean pharmaceutical companies have high hopes of leaping forward this year by boosting research and development to develop new drugs. According to a survey conducted by the Korea Pharmaceutical an...
South Korean drug maker Donga Pharmaceutical said on March 18 that it will roll out its diabetes drug Suganon in India next month. India-based pharmaceutical firm Alkem Laboratories won exclusive...
Several South Korean pharmaceutical companies have decided to make new facility investments in a bid to hone their competitiveness, industry sources said on March 18. The decisions, made at annua...
Prosecutors raided South Korea’s main stock exchange on March 15 as part of a probe into alleged accounting fraud by Samsung BioLogics. Investigators from the Seoul Central District Prosecutors’ ...
South Korean internet giant Naver said on March 15 that it has established a joint venture with Daewoong Pharmaceutical to provide medical data analysis services based on its artificial intellige...
Daewoong Pharmaceutical announced on March 14 that it is negotiating with Vietnam’s second-biggest drug maker Traphaco to expand its presence in the country. The South Korean firm acquired a 15 per...
SillaJen has delayed its board meeting, which was expected to confirm its decision for securing new funds worth around 220 billion won ($194.89 million), according to industry sources on March 14. ...
South Korea’s biotherapeutics company SillaJen ’s stock price fluctuated after a local news outlet reported that the future of its drug candidate Pexa-Vec was murky. Pexa-Vec, which is undergoing ...
South Korean new drug developer GemVax & KAEL announced on March 13 that it has recruited 90 patients to conduct phase 2 clinical trials of its treatment for Alzheimer’s disease. “Since the trials...
LG Chem, South Korea’s top chemical firm, said on March 11 it has received a $33.4 million grant from the Bill & Melinda Gates Foundation to develop a new combination vaccine. The grant will be u...
Celltrion Healthcare announced on March 11 that it won bids to supply Remsima and Truxima to two Southeast Asian countries at the end of last year. For this year, the company will be exclusively sup...
Stonebridge Ventures, spun-off from Korean private equity firm Stonebridge Capital, will invest more in the bio industry this year, according to industry sources on March 8. “Recently, we saw growin...
Korean biopharmaceutical firm Samsung Bioepis will spend 180.4 billion won (US$159.70) to build a new research and development center, its parent company said Thursday. The investment cost accoun...
Daewoong Pharmaceutical announced on March 6 that it posted sales of 1.31 trillion won (US$ 1.16 billion) last year. It has became one of the few Korean pharma firms to reach the milestone. Three ot...
Netmarble Q2 net more than doubles on new games
Notion unveils Korean version to tap into 2nd-largest market
Gooroome lands W2b in pre-A round funding
Talks for HDC-Asiana deal likely to prolong
LG U+ to roll out 5G-powered AR glass service with Nreal
HMM sells stake in Algeciras terminal
SK makes world’s 1st NCM battery with 90% nickel
STIC Investments, Amorepacific and more - this week’s startup and investment update
August 12, 2020
